In Reply:-I thank Dr. Barasch for his insightful comments and for this opportunity to clarify my statement regarding the priority for confirmatory research. Actually, we agree that both laboratory and clinical research findings are strengthened, challenged, or refuted by further studies, and that subtle effects or those which are heavily dependent on the exact conditions of the experiment absolutely require confirmation. In my own field of interest, I note that it took very few studies to establish that the analgesic potency of epidural morphine greatly exceeded that of systemic delivery, but dozens of studies to establish that potency of epidural fentanyl differed little from that of systemic delivery. At this point, it would be very unlikely that yet another study comparing epidural to systemic morphine or fentanyl would meaningfully add to our understanding of analgesic potency, although other factors which were not previously examined in depth, such as opioid-induced immune modulation, might justify such a comparison. My point in the editorial 1 was not that confirmatory research was not wanted in this journal, but rather that we would consider articles addressing the study topics of the retracted papers as being entirely novel rather than confirmatory.
I also thank Dr. Barasch for the suggestion regarding electronic publication of selected articles, and we will discuss the advantages and disadvantages of creating this second class of article within our Editorial Board. As I have quickly observed, this journal, like others in medical science, must continuously and critically review its processes and products to better serve the research and clinical practice communities. 
Concerns Regarding Ultrasound-guided Regional Anesthesia
To the Editor:-Although nerve injuries, including plexopathies, have long been reported, it is time to reflect on situations in which ultrasonic guidance has been used. 1 We are seeing reports of plexopathies after ultrasound-guided regional anesthesia and surgery, despite visualization of the injecting needle tip well away from neural elements.
2,3 At our institution, a case of brachial plexopathy after ultrasound-guided regional anesthesia recently occurred, resolving without sequelae. This disquiet has been increased by the knowledge that ultrasonic guidance for regional anesthesia is being accepted without any safety studies, efficacy studies, or equivalence studies for this particular application. For those of us involved in medical device development, these three steps are essential in assuring patient safety. So, we ask, are there effects heretofore unrecognized in exposing nerves-as in the case of panplexopathies, in particular-to the combination of ultrasound and regional anesthesia?
Nor is this concern limited to anesthesia. The accelerating use of routine sonograms since the 1980s and the accelerating incidence of autism in the 1990s, in light of Ang et al., is troubling and deserving of investigation. 4 The letter of Davies may prove prescient.
5
Almost 40 yr ago, when ultrasound was in its infancy, I worked in an ultrasound laboratory making and evaluating transducer equipment. There I learned that ultrasound is a nifty but high-energy technology with attendant effects, notably cavitation-related mechanical actions and free radical generation. These effects are demonstrably cytotoxic and combine with other cytotoxic agents to produce enhanced cell killing. 6, 7 So what is the concern? Personally, it is that operating room personnel gird their loins as if Armageddon is imminent when the C-arm image intensifier rolls into the room, but use ultrasound for regional anesthesia with little apparent concern for what we do not know: The effects of exposing neural structures to two different sources of neurotoxicity; e.g., local anesthetics and ultrasound.
Ultrasound equipment used for regional anesthesia is described as "low-intensity," but it's still a lot of energy. [7] [8] [9] [10] [11] [12] This, for those of us old enough to remember, is why x-ray machines are no longer found in shoe stores: While it may have been fun to see the bones of our feet on the screen, structures north of the feet should not have been exposed to unnecessary x-rays. In vitro studies describe ultrasound outputs of 5-50 W/cm 2 as "high-intensity." Inspection of product data for one system reveals derated average pulse intensity at maximal mechanical index of 439.3 W/cm 2 . 13 What the apples and oranges comparisons between these values may be is not apparent; however, it is unclear what the low-intensity claim means. This quoted probe value is a calculated quantity derived from data in water and applying an assumed attenuation factor, because no one knows the actual tissue attenuation value.
Ultrasound demonstrates its cytotoxicity in municipal water purification systems and other applications. Thermal effects of high-intensity, focused ultrasound are employed in cancer therapy. However, in our application the cavitation-related shear forces and free-radical production attendant on the very high pressures and temperatures achieved when microbubbles implode in the high-frequency acoustical field are more concerning. 7 The pulse durations and pulse repeat frequencies used for ultrasound-guided regional anesthesia are quite capable of causing both of these effects. For example, ultrasound induces optimal apoptosis in cultured lymphoma cells with a 1 megahertz setup, intensity of 0.3 W/cm 2 , 10% duty cycle, and 100-hertz pulse repeat frequency.
7 These values are entirely within the operational range of our equipment.
How local anesthetic toxicity and ultrasound mechanisms of cellular injury interact is unknown, not to mention the effects of adding, for example, chemotherapeutic agents to the mix. The folate inhibitor methotrexate is a risk factor for plexopathies after total shoulder arthroplasty, and there is a report of a patient on cisplantin sustaining brachial plexopathy after an ultrasound-guided interscalene block.
1,3 Cisplatin, like ultrasound, generates free-radicals. 8 Rather than the pharmacologic double crush the authors describe, perhaps it was in fact a triple crush.
Then there is the question of how tissue response to sonication changes with fluid-filling. Alteration of soft tissue attenuation characteristics by fluid injection is completely unknown, though the assumed
